Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
JDP Therapeutics
JDP Therapeutics
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Quzyttir
Cetirizine
2019-10-04
2030-2032
Allergic rhinitis perennial
,
Urticaria
,
Sinusitis
,
Asthma
,
Common cold
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Cetirizine
malnutrition
,
chronic progressive multiple sclerosis
,
prostatitis
,
pelvic pain
,
migraine disorders
,
larva migrans
,
hepatitis b
,
chronic hepatitis b
,
hepatitis
,
hepatitis a
,
disease
,
syndrome
,
nephrotic syndrome
,
nephrosis
,
hepatitis d
,
schizophrenia
,
psychotic disorders
,
psychotic affective disorders
,
mood disorders
,
mental disorders
,
obsessive-compulsive disorder
,
compulsive behavior
,
paranoid schizophrenia
,
compulsive personality disorder
,
neuromyelitis optica
,
seasonal affective disorder
,
glycogen storage disease type iii
,
glycogen storage disease
,
triple negative breast neoplasms
,
gastrointestinal neoplasms
,
digestive system neoplasms
,
gastrointestinal stromal tumors
,
burns
,
conjunctivitis
,
allergic conjunctivitis
,
dermatitis
,
breast neoplasms
,
atopic dermatitis
,
eczema
,
ovarian neoplasms
,
endometrial neoplasms
,
head and neck neoplasms
,
esophageal neoplasms
,
lung neoplasms
,
uterine cervical neoplasms
,
pemphigus
,
kidney diseases
,
membranous glomerulonephritis
,
ureteral calculi
,
ureterolithiasis
,
rhinitis
,
allergic rhinitis
,
allergic rhinitis seasonal
,
healthy volunteers/patients
,
allergic rhinitis perennial
,
urticaria
,
hypersensitivity
,
chronic urticaria
,
asthma
,
multiple sclerosis
,
covid-19
,
pruritus
,
alopecia areata
,
alopecia
,
neoplasms
,
sclerosis
,
hypoxia
,
inflammation
,
relapsing-remitting multiple sclerosis
,
otitis media
,
otitis
,
otitis media with effusion
,
altitude sickness
,
type 2 diabetes mellitus
,
neuralgia
,
diabetic neuropathies
,
irritable bowel syndrome
,
diarrhea
,
cognition
,
actinic keratosis
,
keratosis
,
sinusitis
,
vasomotor rhinitis
,
peripheral nervous system diseases
Terfenadine
neoplasms
,
carcinoma in situ
,
cervical intraepithelial neoplasia
,
uterine cervical dysplasia
Sominex
non-hodgkin lymphoma
,
lymphoma
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use